newsfilter
← Latest News
Business Wire·

Checkmate Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference

Checkmate Pharmaceuticals Inc. (NASDAQ:CMPI) ("Checkmate"), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced that Barry Labinger, CEO,